rdf:type |
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0019704,
umls-concept:C0021311,
umls-concept:C0030705,
umls-concept:C0037712,
umls-concept:C0205191,
umls-concept:C0205466,
umls-concept:C0205470,
umls-concept:C0243009,
umls-concept:C0449560,
umls-concept:C0547047,
umls-concept:C0599755,
umls-concept:C1274040,
umls-concept:C1707391
|
pubmed:issue |
6
|
pubmed:dateCreated |
2009-8-21
|
pubmed:abstractText |
The extent to which immunologic and clinical biomarkers influence human immunodeficiency virus type 1 (HIV-1) infection outcomes remains incompletely characterized, particularly for non-B subtypes. On the basis of data supporting in vitro HIV-1 protein-specific CD8 T lymphocyte responses as correlates of immune control in cross-sectional studies, we assessed the relationship of these responses, along with established HIV-1 biomarkers, with rates of CD4 cell count decrease in individuals infected with HIV-1 subtype C.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1537-6591
|
pubmed:author |
pubmed-author:BishopKarenK,
pubmed-author:BranderChristianC,
pubmed-author:BrummeChansonC,
pubmed-author:BrummeZabrinaZ,
pubmed-author:CarringtonMaryM,
pubmed-author:ChoncoFundisiweF,
pubmed-author:FrahmNicoleN,
pubmed-author:FreedbergKennethK,
pubmed-author:GoulderPhilipP,
pubmed-author:JulgBorisB,
pubmed-author:KiepielaPhotiniP,
pubmed-author:LosinaElenaE,
pubmed-author:LuZhigangZ,
pubmed-author:MncubeZeneleZ,
pubmed-author:MoodleyEshiaE,
pubmed-author:NairKriebashneK,
pubmed-author:Ndung'uThumbiT,
pubmed-author:ReddyShabashiniS,
pubmed-author:ThobakgaleChristinaC,
pubmed-author:ValentiniValentinoV,
pubmed-author:WalkerBruceB,
pubmed-author:WangBingxiaB,
pubmed-author:de PierresChantalC,
pubmed-author:van der StokMaryM
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
956-64
|
pubmed:dateRevised |
2010-12-3
|
pubmed:meshHeading |
pubmed-meshheading:19663693-Adult,
pubmed-meshheading:19663693-Alleles,
pubmed-meshheading:19663693-Biological Markers,
pubmed-meshheading:19663693-CD4 Lymphocyte Count,
pubmed-meshheading:19663693-CD4-CD8 Ratio,
pubmed-meshheading:19663693-CD8-Positive T-Lymphocytes,
pubmed-meshheading:19663693-Cohort Studies,
pubmed-meshheading:19663693-Female,
pubmed-meshheading:19663693-HIV Infections,
pubmed-meshheading:19663693-HIV-1,
pubmed-meshheading:19663693-HLA Antigens,
pubmed-meshheading:19663693-Humans,
pubmed-meshheading:19663693-Longitudinal Studies,
pubmed-meshheading:19663693-Male,
pubmed-meshheading:19663693-Multivariate Analysis,
pubmed-meshheading:19663693-Predictive Value of Tests,
pubmed-meshheading:19663693-South Africa,
pubmed-meshheading:19663693-Viral Load
|
pubmed:year |
2009
|
pubmed:articleTitle |
Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.
|
pubmed:affiliation |
Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural,
Research Support, N.I.H., Intramural
|